NOVAGO
LIVE

Serial Number

99466281

Owner

NovaGo Therapeutics AG

Attorney

Janice Housey

Filing Date

Oct 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NOVAGO Trademark

Serial Number: 99466281

NOVAGO is a trademark filed by NovaGo Therapeutics AG on October 28, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

NovaGo Therapeutics AG (3 trademarks)

Wagistrasse 27
Schlieren 8952 , CH

Entity Type: 99

Trademark Details

Filing Date

October 28, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for treatment of central and peripheral nervous system injuries; preparations for immunotherapeutic purposes related to diseases of the immune system; Pharmaceutical products for the suppression of tumors; Pharmaceutical preparations for neurodegenerative diseases; Pharmaceutical products being immunogens for medical use; vaccines, antibodies for medical purposes, epitopes for pharmaceutical use; Synthetic peptides for pharmaceutical purposes; sanitary preparations for medical use; biological preparations for use in cell cultures for medical use; biocides; diagnostic products being diagnostic agents for medical use; towels for hygiene purposes, namely, wipes impregnated with disinfectants for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposes

Chemical products for use in the development of biologics, specifically therapeutic antibodies; Chemical preparations for general industrial manufacturing purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes for use in the manufacture of biologics, specifically therapeutic antibodies; biological preparations, namely, biologics, specifically therapeutic antibodies other than for medical or veterinary use; Chemical products in the nature of peptides for manufacture of chemical products and foodstuffs; polypeptides in the nature of biochemical preparations for scientific use; Biochemicals, namely, antibodies and proteins for scientific use

Medical services; medical services in the field of immunity; provision of medical information; medical examinations; preparation and dispensing of medicines; consultancy and provision of information in the field of sanitary care; health care; consultancy and provision of information relating to the operation, preparation, dispensing and dosage of pharmaceutical preparations

Monitoring and inspection for the quality control and analysis of active substances, as well as research involving pharmaceutical products, cosmetics or foodstuffs; consultancy and information on monitoring and inspection for the quality control and analysis of active substances, as well as research involving pharmaceutical products, cosmetics or foodstuffs; monitoring and inspection for the quality control and analysis of active substances, as well as research involving medical treatment and methods; research in the fields of biotechnology and antibodies; Providing information on monitoring and inspection for the quality control and analysis of active substance testing and research in technical and medical treatment; Providing research in the field of sanitary care; monitoring, inspection for quality control of pharmaceutical products and research in the field of biology; computer software design, computer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparations; software maintenance

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 28, 2025 MAFR
NEW APPLICATION ENTERED
Oct 28, 2025 NWAP